Amalgamated Bank
- SEC CIK
- 0000919192
- Latest filing
- Jul 23, 2026
YMAB holding history
Y-mAbs Therapeutics, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
YMAB overviewAll 13F holders of YMABFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −1,217−100.0% | Sold out | Holders |
| Q2 2025 | 1,217 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,217 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,217 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,217 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,217 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,217 | $20.0K | <0.1% | −2,904−70.5% | Reduced | Holders |
| Q4 2023 | 4,121 | $28.0K | <0.1% | −362−8.1% | Reduced | Holders |
| Q3 2023 | 4,483 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 4,483 | $30.0K | <0.1% | −566−11.2% | Reduced | Holders |
| Q1 2023 | 5,049 | $25.0K | <0.1% | −770−13.2% | Reduced | Holders |
| Q4 2022 | 5,819 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 5,819 | $84.0K | <0.1% | +92+1.6% | Added | Holders |
| Q2 2022 | 5,727 | $87.0K | <0.1% | +21+0.4% | Added | Holders |
| Q1 2022 | 5,706 | $68.0K | <0.1% | +5,706 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −6,599−100.0% | Sold out | Holders |
| Q2 2021 | 6,599 | $223.0K | <0.1% | +6,599 | New | Holders |